{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:08:52Z","timestamp":1793052532738,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaad.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T01:59:43Z","timestamp":1562810383000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature"],"prefix":"10.1016","volume":"82","author":[{"given":"H\u00e9l\u00e8ne","family":"Traineau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Beno\u00eet","family":"Monfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Senet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester V.","family":"Oddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Chizzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Franc\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BOR.0b013e32834ff5cd","article-title":"Soft tissue and subcutaneous calcification in connective tissue diseases","volume":"24","author":"Chander","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2019.07.006_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0190-9622(95)91803-5","article-title":"Calcifying disorders of the skin","volume":"33","author":"Walsh","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.07.006_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","article-title":"Risk factors associated with calcinosis of juvenile dermatomyositis","volume":"84","author":"Sallum","year":"2008","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.jaad.2019.07.006_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0482-50042012000400007","article-title":"High frequency of calcinosis in juvenile dermatomyositis: a risk factor study","volume":"52","author":"Clemente","year":"2012","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.07.006_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr.22142","article-title":"Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry: investigating juvenile DM through a national multicenter registry","volume":"66","author":"Robinson","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"51","key":"10.1016\/j.jaad.2019.07.006_bib8","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jaad.2019.07.006_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-016-3412-9","article-title":"Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis","volume":"36","author":"Cruz-Dom\u00ednguez","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/ard.57.4.252","article-title":"Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?","volume":"57","author":"Vayssairat","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.jaad.2019.07.006_bib11","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3899\/jrheum.100627","article-title":"Role of fetuin-A in systemic sclerosis-associated calcinosis","volume":"37","author":"Belloli","year":"2010","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.07.006_bib12","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/rheumatology\/kew313","article-title":"Calcinosis is associated with digital ischaemia in systemic sclerosis\u2014a longitudinal study","volume":"55","author":"Baron","year":"2016","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jaad.2019.07.006_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jbspin.2008.07.003","article-title":"Systemic sclerosis: an update in 2008","volume":"75","author":"Allanore","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.jaad.2019.07.006_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","article-title":"Morbidity and mortality in adult polymyositis and dermatomyositis","volume":"14","author":"Marie","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10.1016\/j.jaad.2019.07.006_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.autrev.2018.02.008","article-title":"Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort","volume":"17","author":"Panopoulos","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib16","first-page":"575","article-title":"Calcinosis Cutis of juvenile dermatomyositis treated with incision and drainage","volume":"34","author":"Wu","year":"2008","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2019.07.006_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.jaad.2019.07.006_bib18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2019.07.006_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-9343(87)90499-2","article-title":"Treatment of calcinosis universalis with low-dose warfarin","volume":"83","author":"Berger","year":"1987","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jaad.2019.07.006_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/BOR.0000000000000539","article-title":"Calcinosis in scleroderma","volume":"30","author":"Valenzuela","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2019.07.006_bib22","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.jaad.2019.07.006_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-9343(88)90128-3","article-title":"Failure of warfarin in treatment of calcinosis universalis","volume":"84","author":"Lassoued","year":"1988","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.jaad.2019.07.006_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ard.2003.014431","article-title":"Low dose warfarin treatment for calcinosis in patients with systemic sclerosis","volume":"63","author":"Cukierman","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","article-title":"Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009","volume":"148","author":"Balin","year":"2012","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2019.07.006_bib29","article-title":"SAT0469 calcinosis cutis in poly-dermatomyositis: clinical and therapeutic study","volume":"74","author":"Fredi","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/kew396","article-title":"Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab","volume":"56","author":"Aggarwal","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ced.12450","article-title":"Dosage of rituximab in systemic sclerosis: 2-year results of five cases","volume":"40","author":"Moazedi-Fuerst","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl 10","key":"10.1016\/j.jaad.2019.07.006_bib32","first-page":"S737","article-title":"Long-term efficacy of rituximab in systemic sclerosis","volume":"66","author":"Narv\u00e1ez","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2019.07.006_bib33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","article-title":"Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature","volume":"14","author":"Giuggioli","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.jaad.2019.07.006_bib34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3899\/jrheum.101321","article-title":"Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab Registry","volume":"38","author":"Bader-Meunier","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2019.07.006_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4236\/ojra.2017.71002","article-title":"Effectiveness of rituximab therapy on severe calcinosis in 4 children with juvenile dermatomyositis","volume":"7","author":"Alhemairi","year":"2017","journal-title":"Open J Rheumatol Autoimmune Dis"},{"issue":"6","key":"10.1016\/j.jaad.2019.07.006_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology"},{"issue":"Suppl 4","key":"10.1016\/j.jaad.2019.07.006_bib37","first-page":"137","article-title":"Abatacept as adjunct therapy for the calcinosis of juvenile dermatomyositis: a single-center experience","volume":"69","author":"DeGuzman","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2019.07.006_bib38","doi-asserted-by":"crossref","first-page":"O29","DOI":"10.1186\/1546-0096-9-S1-O29","article-title":"Effectiveness of anti-TNF-\u03b1 agents in the treatment of refractory juvenile dermatomyositis","volume":"9","author":"Boulter","year":"2011","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.07.006_bib39","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis","volume":"28","author":"Marco Puche","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/14397595.2014.988197","article-title":"Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis","volume":"25","author":"Tayfur","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2019.07.006_bib41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00296-016-3467-6","article-title":"Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome","volume":"36","author":"Saini","year":"2016","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.jaad.2019.07.006_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaad.2015.03.047","article-title":"Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis","volume":"73","author":"Galimberti","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2133.1996.tb01166.x","article-title":"Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser","volume":"135","author":"Bottomley","year":"1996","journal-title":"Br J Dermatol"},{"issue":"Suppl 100(5)","key":"10.1016\/j.jaad.2019.07.006_bib44","first-page":"177","article-title":"Safety and efficacy of extracorporeal shock wave therapy (ESWT) in calcinosis cutis associated with systemic sclerosis","volume":"34","author":"Blumhardt","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.07.006_bib45","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaad.2010.12.035","article-title":"Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy","volume":"66","author":"Sultan-Bichat","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/keh536","article-title":"A pilot study of acetic acid iontophoresis and ultrasound in the treatment of systemic sclerosis-related calcinosis","volume":"44","author":"Shetty","year":"2005","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.jaad.2019.07.006_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s002380050122","article-title":"Microdrilling of digital calcinosis","volume":"21","author":"Fahmy","year":"1998","journal-title":"Eur J Plast Surg"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2019.07.006_bib48","article-title":"AB0617 effect of sodium thiosulfate on calcinosis cutis associated with connective tissue disease","volume":"73","author":"Trysberg","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2019.07.006_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbspin.2016.10.009","article-title":"Intravenous sodium thiosulfate for treating tumoral calcinosis associated with systemic disorders: report of four cases","volume":"84","author":"Mageau","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.jaad.2019.07.006_bib50","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjd.14412","article-title":"Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy","volume":"175","author":"del Barrio-D\u00edaz","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2340\/00015555-2206","article-title":"Treatment of skin calcifications with intra-lesional injection of sodium thiosulphate: a case series","volume":"96","author":"Baumgartner-Nielsen","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2019.07.006_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.62.3.267","article-title":"Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline","volume":"62","author":"Robertson","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2019.07.006_bib53","doi-asserted-by":"crossref","first-page":"P143","DOI":"10.1186\/1546-0096-11-S2-P143","article-title":"PReS-FINAL-2130-A: effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland","volume":"11","author":"Moraitis","year":"2013","journal-title":"Pediatr Rheumatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.07.006_bib54","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ard.2003.014431","article-title":"Low dose warfarin treatment for calcinosis in patients with systemic sclerosis","volume":"63","author":"Cukierman","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.jaad.2019.07.006_bib55","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2019.07.006_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/clc.20865","article-title":"Association of warfarin use with valvular and vascular calcification: a review","volume":"34","author":"Palaniswamy","year":"2011","journal-title":"Clin Cardiol"},{"issue":"6","key":"10.1016\/j.jaad.2019.07.006_bib57","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2017.12.010","article-title":"Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review","volume":"17","author":"Thiebaut","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.jaad.2019.07.006_bib58","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2005.044453","article-title":"Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jaad.2019.07.006_bib59","first-page":"642","article-title":"Surgery of the hand in patients with systemic sclerosis: outcomes and considerations","volume":"32","author":"Bogoch","year":"2005","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.07.006_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamadermatol.2017.4374","article-title":"Treatment for livedoid vasculopathy: a systematic review","volume":"154","author":"Micieli","year":"2018","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219323187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219323187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:53:15Z","timestamp":1759272795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219323187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0190962219323187"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.07.006","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}